← Back to Clinical Trials
Recruiting NCT07490132

Endoscopic Retrograde Cholangiopancreatography

Trial Parameters

Condition Gastro-Intestinal Disorder
Sponsor Methodist Health System
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 15 Years
Max Age N/A
Start Date 2026-02
Completion 2027-02
Interventions
Patients undergoing ERCPs at Methodist Dallas Medical Center

Brief Summary

The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.

Eligibility Criteria

Inclusion Criteria: Patients \>15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025 Exclusion Criteria: Patients \<15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.

Related Trials